Custom antibody–polymer conjugation services including antibody PEGylation, antibody–synthetic polymer conjugation, antibody–dendrimer conjugation, and advanced biopolymer platforms for improved stability, solubility, circulation half-life, and targeted delivery.
Antibody–polymer conjugation (APC) and antibody–biopolymer conjugation (ABC) combine the targeting specificity of antibodies with the functional advantages of polymers to generate next-generation therapeutic, diagnostic, and delivery systems.
By conjugating antibodies to PEG, synthetic polymers, dendrimers, and other polymer architectures, these systems can improve pharmacokinetics, reduce clearance, increase stability, enhance payload handling, and support customized release profiles.
Our platform supports antibody PEGylation in different sizes as well as customized antibody–synthetic polymer and antibody–dendrimer conjugation projects using the same modular polymer capabilities commonly used for oligonucleotide–polymer conjugation.
Match antibody targeting with polymer-enabled performance tuning for solubility, half-life, shielding, multivalency, and controlled delivery.
Use antibody recognition to direct polymer-functional systems toward defined cellular or molecular targets.
Polymers can improve circulation, protect sensitive biomolecules, and support more robust conjugate behavior.
Select polymer type, molecular weight, architecture, and linker strategy based on your application and molecule.
Extend circulation half-life and reduce rapid clearance.
Improve handling of hydrophobic or difficult payloads and constructs.
Increase resistance to degradation during storage and in biological environments.
Combine antibody specificity with controlled polymer-enabled delivery.
Dendrimers and multi-arm polymers can support higher loading or multivalent formats.
Use cleavable or responsive systems for application-specific activation or release.
Expand a platform below to view representative options, primary functions, and common use notes.
Antibody specificity combined with polymer-mediated performance tuning for targeted delivery concepts.
Use PEG or polymer systems to improve solubility, handling, and stability of difficult payload formats.
Support antibody-directed conjugates for detection, imaging, and assay-readout systems.
Build responsive or multivalent polymer formats for targeted immune-related research concepts.
Combine antibody targeting with polymer-assisted delivery for nucleic acid or hybrid therapeutic designs.
Explore related antibody conjugation services for other molecule classes and payload formats.
Custom conjugation of antibodies to DNA or RNA oligonucleotides for sequencing, detection, and spatial biology workflows.
Custom antibody conjugation to functional ligands, reporters, and other small-molecule systems.
Custom antibody–drug conjugation services for cytotoxic and other drug-like payload classes.
We support antibody PEGylation as well as antibody conjugation to selected synthetic polymers, dendrimers, and biopolymer or responsive polymer systems depending on project goals and chemistry compatibility.
Yes. Antibody PEGylation can be performed using different PEG molecular weights and architectures, including linear, branched, and multi-arm formats, depending on the intended application.
Polymer conjugation can improve antibody stability, solubility, circulation half-life, shielding, and delivery behavior while preserving the targeting advantages of the antibody.
In many cases, yes. The same modular polymer platform used for oligonucleotide–polymer conjugation can often be adapted for antibody–polymer conjugation with chemistry and workflow adjustments tailored to antibodies.
Strategy selection depends on antibody format, desired site control, polymer architecture, payload or application needs, and whether stable or cleavable linkage behavior is preferred.
Please provide antibody format, polymer type or target platform, preferred chemistry if known, required quantity, and the intended application so the best conjugation route can be evaluated.
For the fastest review, please share your antibody format, preferred polymer platform, target application, and any known linker or conjugation preferences. This helps define a practical route for polymer selection, conjugation chemistry, purification, and characterization.
Send your project details and our team can review polymer options, conjugation feasibility, and next-step recommendations.
Trusted by biotech leaders worldwide for over 45+ years of delivering high quality, fast and scalable synthetic biology solutions.